DK1492440T3 - Fremgangsmåde til opnåelse af en diagnose og prognose for maligne sygdomme - Google Patents
Fremgangsmåde til opnåelse af en diagnose og prognose for maligne sygdommeInfo
- Publication number
- DK1492440T3 DK1492440T3 DK03728350T DK03728350T DK1492440T3 DK 1492440 T3 DK1492440 T3 DK 1492440T3 DK 03728350 T DK03728350 T DK 03728350T DK 03728350 T DK03728350 T DK 03728350T DK 1492440 T3 DK1492440 T3 DK 1492440T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- prognosis
- obtaining
- malignant diseases
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/118,854 US7541150B2 (en) | 2002-04-08 | 2002-04-08 | Method for the diagnosis and prognosis of malignant diseases |
PCT/US2003/010745 WO2003086174A2 (fr) | 2002-04-08 | 2003-04-08 | Methode de diagnostic et de pronostic de maladies malignes |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1492440T3 true DK1492440T3 (da) | 2008-09-22 |
Family
ID=28789881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03728350T DK1492440T3 (da) | 2002-04-08 | 2003-04-08 | Fremgangsmåde til opnåelse af en diagnose og prognose for maligne sygdomme |
Country Status (10)
Country | Link |
---|---|
US (1) | US7541150B2 (fr) |
EP (1) | EP1492440B8 (fr) |
JP (3) | JP4841109B2 (fr) |
AT (1) | ATE398138T1 (fr) |
AU (1) | AU2003234694B8 (fr) |
CA (1) | CA2490724C (fr) |
DE (1) | DE60321552D1 (fr) |
DK (1) | DK1492440T3 (fr) |
ES (1) | ES2307936T3 (fr) |
WO (1) | WO2003086174A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7960540B2 (en) * | 1999-04-08 | 2011-06-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
US8114850B2 (en) * | 1999-04-08 | 2012-02-14 | Advanced Cancer Therapeutics, Llc | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
US20110178161A1 (en) * | 1999-04-08 | 2011-07-21 | Antisoma Research Limited | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
ES2296615T3 (es) * | 1999-04-08 | 2008-05-01 | Antisoma Research Limited | Actividad antiproliferativa de oligonucleotidos ricos en g y procedimiento de uso de los mismos para su union a la nucleolina. |
JP2005517718A (ja) * | 2002-02-19 | 2005-06-16 | シンセリカ・コーポレイション | 免疫応答および輸送の代替抗体による調整のための組成物および方法 |
US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
US7541150B2 (en) | 2002-04-08 | 2009-06-02 | University Of Louisville Research Foundation, Inc | Method for the diagnosis and prognosis of malignant diseases |
US7357928B2 (en) | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
JP2005530515A (ja) * | 2002-06-26 | 2005-10-13 | ユニヴァーシティー オヴ ルイスヴィル リサーチ ファウンデイション インコーポレイテッド | アポトーシスの検出方法 |
US7858323B2 (en) * | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
EP1767942A4 (fr) * | 2004-06-14 | 2008-07-16 | Kyowa Medex Co Ltd | Procede de dosage immunoenzymatique ayant une reaction non specifique inhibee et reactif pour celui-ci |
US20060073534A1 (en) * | 2004-10-05 | 2006-04-06 | The University Of Georgia Research Foundation, Inc | Method for cleaving and deglycosylating antibodies to promote ligand binding |
CN1862258B (zh) | 2005-05-12 | 2012-05-30 | 清华大学 | 核仁素辅助的癌症诊断与治疗方法 |
US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
JP5781762B2 (ja) * | 2007-08-10 | 2015-09-24 | プロテリックス、インク | ユニバーサルiii型フィブロネクチン結合ドメインのライブラリ |
US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
US20090131351A1 (en) * | 2007-11-16 | 2009-05-21 | Antisoma Research Limited | Methods, compositions, and kits for modulating tumor cell proliferation |
US20090226914A1 (en) * | 2007-12-31 | 2009-09-10 | Bates Paula J | Methods and products to target, capture and characterize stem cells |
WO2011062997A2 (fr) * | 2009-11-17 | 2011-05-26 | Musc Foundation For Research Development | Anticorps monoclonaux humains pour nucléoline humaine |
CN101782573B (zh) * | 2010-01-11 | 2014-09-10 | 天津师范大学 | 检测重金属胁迫下核仁c23蛋白质定位的免疫荧光方法 |
WO2011116209A2 (fr) | 2010-03-17 | 2011-09-22 | The Regents Of The University Of Michigan | Utilisation d'épitopes de phage à des fins de profilage de la réponse immunitaire |
US20110237457A1 (en) * | 2010-03-26 | 2011-09-29 | Armune Biosciences, Inc. | Method and system of particle-coupled phage epitope |
ES2880291T3 (es) | 2011-06-02 | 2021-11-24 | Univ Louisville Res Found Inc | Nanopartículas conjugadas a un agente antinucleolina |
US20130023479A1 (en) * | 2011-07-22 | 2013-01-24 | Protgen Ltd. | Use of nucleolin as a biomarker for lymphangiogenesis in cancer prognosis and therapy |
WO2016179394A1 (fr) | 2015-05-05 | 2016-11-10 | Malik Mohammad Tariq | Nanoparticules conjuguées à un agent antinucléoline en tant que radiosensibiliseurs et agents de contraste d'imagerie par résonance magnétique (irm) et/ou en rayons x |
ES2770787T3 (es) | 2016-02-19 | 2020-07-03 | Siwa Corp | Método y composición para tratar el cáncer, destruir las células cancerosas metastásicas y evitar la metástasis del cáncer usando anticuerpo para productos finales de glicación avanzada (AGE) |
WO2017181049A1 (fr) * | 2016-04-15 | 2017-10-19 | Charlestonpharma, Llc | Agents anti-nucléoline |
EP3493852A1 (fr) | 2016-08-02 | 2019-06-12 | University of Louisville Research Foundation, Inc. | Émulsions de nanogouttelettes ciblées pour le traitement du cancer |
KR20190130138A (ko) * | 2017-03-20 | 2019-11-21 | 캔서 테라퓨틱스 래버러토리즈 인코포레이티드 | 종양 괴사 표적화 조성물 및 방법 |
WO2021050779A2 (fr) | 2019-09-10 | 2021-03-18 | University Of Louisville Research Foundation, Inc. | Nanoparticules conjuguées à un peg et à un agent antinucléoline |
WO2021138397A1 (fr) * | 2019-12-30 | 2021-07-08 | Ohio State Innovation Foundation | Protéines en boucle comprenant des peptides de pénétration cellulaire |
WO2021202425A1 (fr) | 2020-03-28 | 2021-10-07 | University Of Louisville Research Foundation, Inc. | Méthodes d'inhibition ou de traitement d'une infection par coronavirus, et méthodes d'administration d'un agent anti-nucléoline |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4474892A (en) * | 1983-02-16 | 1984-10-02 | Board Of Trustees Of The Leland Stanford Junior University | Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same |
US5169774A (en) * | 1984-02-08 | 1992-12-08 | Cetus Oncology Corporation | Monoclonal anti-human breast cancer antibodies |
US4665897A (en) * | 1984-05-25 | 1987-05-19 | Lemelson Jerome H | Composition and method for detecting and treating cancer |
US4987071A (en) * | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5223427A (en) * | 1987-03-31 | 1993-06-29 | The Scripps Research Institute | Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain |
GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5192660A (en) * | 1989-04-24 | 1993-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | ELISA methods for the determination of human platelet derived growth factor (PDGF) dimer forms present in human tissues and fluids |
AU635008B2 (en) * | 1989-12-13 | 1993-03-11 | Genelabs Diagnostics Pte Ltd | Analytical apparatus and method for automated blot assay |
US5770429A (en) * | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5736348A (en) * | 1990-11-28 | 1998-04-07 | Fundacao Oswaldo Cruz (Fiocruz) | Method for the immunological diagnosis of Chagas' Disease using recombinant antigens |
JPH05244988A (ja) * | 1992-03-04 | 1993-09-24 | Green Cross Corp:The | 抗組織因子モノクローナル抗体、及びこれによる免疫抑制剤 |
AU1736495A (en) | 1994-01-31 | 1995-08-15 | Trustees Of Boston University | Polyclonal antibody libraries |
JPH07242566A (ja) | 1994-03-01 | 1995-09-19 | Kirin Brewery Co Ltd | 免疫抑制剤 |
US6096532A (en) * | 1995-06-07 | 2000-08-01 | Aastrom Biosciences, Inc. | Processor apparatus for use in a system for maintaining and growing biological cells |
US5567660A (en) * | 1995-09-13 | 1996-10-22 | Taiwan Semiconductor Manufacturing Company Ltd | Spin-on-glass planarization by a new stagnant coating method |
US6013487A (en) | 1995-12-15 | 2000-01-11 | Mitchell; Lloyd G. | Chimeric RNA molecules generated by trans-splicing |
US6048703A (en) * | 1996-11-15 | 2000-04-11 | Cephalon, Inc. | Methods for detecting cell apoptosis |
KR100942002B1 (ko) | 1996-12-03 | 2010-02-12 | 암젠 프레몬트 인코포레이티드 | 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린 유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된 항체 |
EP1007669A1 (fr) | 1997-03-12 | 2000-06-14 | Institut Pasteur | Recepteur membranaire pour retrovirus de vih, utilisations therapeutiques et diagnostiques |
CA2293724C (fr) * | 1997-06-05 | 2010-02-02 | Xiaodong Wang | Apaf-1, homologue humain de ced-4, activateur de caspase-3 |
DE69839147T2 (de) * | 1997-06-12 | 2009-02-19 | Novartis International Pharmaceutical Ltd. | Künstliche antikörperpolypeptide |
US6339075B1 (en) * | 1997-06-30 | 2002-01-15 | The University Of British Columbia | Use of dextran and other polysaccharides to improve mucus clearance |
WO1999006588A1 (fr) | 1997-08-04 | 1999-02-11 | The Burnham Institute | Systeme exempt de cellules relatif a l'apoptose a dependance mitochondriale et techniques d'application |
US6325785B1 (en) * | 1997-08-14 | 2001-12-04 | Sherwood Services Ag | Sputum trap manifold with nested caps |
US5925334A (en) * | 1997-08-27 | 1999-07-20 | Rubin; Bruce K. | Use of surface active agents to promote mucus clearance |
US5932475A (en) * | 1997-12-12 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Human nucleolin-like protein |
US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
US6306404B1 (en) * | 1998-07-14 | 2001-10-23 | American Cyanamid Company | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
ATE382148T1 (de) * | 1998-09-24 | 2008-01-15 | Promega Corp | Antikörper für apoptosemarker und anwendungsverfahren |
ES2296615T3 (es) * | 1999-04-08 | 2008-05-01 | Antisoma Research Limited | Actividad antiproliferativa de oligonucleotidos ricos en g y procedimiento de uso de los mismos para su union a la nucleolina. |
CA2363984A1 (fr) | 1999-04-15 | 2000-10-26 | Merck Frosst Canada & Co. | Anticorps reconnaissant l'app clivee par les caspases et leurs procedes d'utilisation |
US6165786A (en) | 1999-11-03 | 2000-12-26 | Isis Pharmaceuticals, Inc. | Antisense modulation of nucleolin expression |
JP3869722B2 (ja) | 1999-11-08 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 細胞死の検出方法及び検出試薬 |
JP2001213804A (ja) * | 2000-01-31 | 2001-08-07 | Chugai Pharmaceut Co Ltd | 抗組織因子抗体の複合体 |
IL151781A0 (en) | 2000-03-16 | 2003-04-10 | Genetica Inc | Methods and compositions for rna interference |
JP5500750B2 (ja) | 2000-03-30 | 2014-05-21 | ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ | Rna干渉のrna配列特異的メディエータ |
JP2004505894A (ja) | 2000-06-02 | 2004-02-26 | ユニバーシティー オブ コネティカット ヘルス センター | 免疫療法のためのα(2)マクログロブリンと抗原分子との複合体 |
US20020028488A1 (en) * | 2000-06-19 | 2002-03-07 | Sujay Singh | Transgenic avian species for making human and chimeric antibodies |
DE10037861A1 (de) | 2000-08-01 | 2002-02-14 | Max Delbrueck Centrum | Mittel zur Therapie maligner Erkrankungen |
IL154751A0 (en) | 2000-08-03 | 2003-10-31 | Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals | |
DE10059821A1 (de) | 2000-12-01 | 2002-06-13 | Clariant Gmbh | Tensidfreie kosmetische, dermatologische und pharmazeutische Mittel |
JP3676991B2 (ja) | 2001-07-05 | 2005-07-27 | 松下電器産業株式会社 | 無線通信装置及び無線通信方法 |
AU2002362436A1 (en) | 2001-10-03 | 2003-04-14 | Rigel Pharmaceuticals, Inc. | Modulators of lymphocyte activation and migration |
AU2003228431A1 (en) | 2002-04-05 | 2003-10-27 | The Burnham Institute | Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
US7357928B2 (en) | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
US7541150B2 (en) | 2002-04-08 | 2009-06-02 | University Of Louisville Research Foundation, Inc | Method for the diagnosis and prognosis of malignant diseases |
JP2005530515A (ja) | 2002-06-26 | 2005-10-13 | ユニヴァーシティー オヴ ルイスヴィル リサーチ ファウンデイション インコーポレイテッド | アポトーシスの検出方法 |
-
2002
- 2002-04-08 US US10/118,854 patent/US7541150B2/en not_active Expired - Fee Related
-
2003
- 2003-04-08 DK DK03728350T patent/DK1492440T3/da active
- 2003-04-08 DE DE60321552T patent/DE60321552D1/de not_active Expired - Lifetime
- 2003-04-08 CA CA2490724A patent/CA2490724C/fr not_active Expired - Fee Related
- 2003-04-08 ES ES03728350T patent/ES2307936T3/es not_active Expired - Lifetime
- 2003-04-08 EP EP03728350A patent/EP1492440B8/fr not_active Expired - Lifetime
- 2003-04-08 AT AT03728350T patent/ATE398138T1/de not_active IP Right Cessation
- 2003-04-08 AU AU2003234694A patent/AU2003234694B8/en not_active Ceased
- 2003-04-08 JP JP2003583205A patent/JP4841109B2/ja not_active Expired - Fee Related
- 2003-04-08 WO PCT/US2003/010745 patent/WO2003086174A2/fr active Application Filing
-
2011
- 2011-06-07 JP JP2011127396A patent/JP2011246467A/ja active Pending
-
2012
- 2012-12-06 JP JP2012266961A patent/JP5712198B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5712198B2 (ja) | 2015-05-07 |
ES2307936T3 (es) | 2008-12-01 |
EP1492440B8 (fr) | 2008-07-16 |
US7541150B2 (en) | 2009-06-02 |
EP1492440A4 (fr) | 2005-08-24 |
JP2005526968A (ja) | 2005-09-08 |
DE60321552D1 (de) | 2008-07-24 |
AU2003234694B8 (en) | 2008-10-23 |
JP4841109B2 (ja) | 2011-12-21 |
AU2003234694A1 (en) | 2003-10-27 |
JP2011246467A (ja) | 2011-12-08 |
AU2003234694B2 (en) | 2008-05-15 |
WO2003086174A2 (fr) | 2003-10-23 |
EP1492440A2 (fr) | 2005-01-05 |
CA2490724A1 (fr) | 2003-10-23 |
JP2013100295A (ja) | 2013-05-23 |
EP1492440B1 (fr) | 2008-06-11 |
WO2003086174A3 (fr) | 2004-09-23 |
ATE398138T1 (de) | 2008-07-15 |
CA2490724C (fr) | 2010-12-21 |
US20030194754A1 (en) | 2003-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1492440T3 (da) | Fremgangsmåde til opnåelse af en diagnose og prognose for maligne sygdomme | |
DK1877559T3 (da) | Mitochondrial mutationer og omarrangeringer som et diagnostisk værktøj for detektion af soleksponering, prostatacancer og andre cancertyper | |
NO20074474L (no) | Antistoffer som binder til EPHA2 og fremgangsmate for anvendelse derav | |
NO20071309L (no) | Fremgangsmate for ekspansjon | |
TWI317811B (fr) | ||
ATE514755T1 (de) | Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung | |
DK3489689T3 (da) | Bestemmelse af neutrofil gelatinase-associeret lipocalin (NGAL) som diagnostisk markør for nyresygdomme | |
DE602006006200D1 (de) | Antikörper gegen 25-hydroxyvitamin d | |
DK1092155T3 (da) | Fremgangsmåde til tidlig diagnose af carcinomer | |
ATE539170T1 (de) | Abschätzung und verringerung des risikos von graft-versus-host-reaktion | |
DK1940918T3 (da) | Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme | |
ATE509033T1 (de) | Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting | |
GB2424480A (en) | Prostate stem cell | |
DK1869475T3 (da) | In vitro metode til samtidig detektering og identifikation af antibiotika i forskellige klasser og et tilsvarende diagnosekit | |
ATE456666T1 (de) | Verfahren zur auswertung von ribonukleotidsequenzen | |
DE60331310D1 (de) | Verfahren zum apoptosenachweis | |
WO2007030949A3 (fr) | Procedes de diagnostic de cancer des ovaires et necessaires a cet effet | |
EA201492284A1 (ru) | Применение маркеров в диагностике и лечении рака предстательной железы | |
WO2008073895A3 (fr) | Procédés et dispositifs d'analyse de la salive | |
ATE403151T1 (de) | Trägerplatte zur durchführung funktioneller tests an biologischen zellen sowie verfahren zur beschichtung der trägerplatte | |
DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
ATE416262T1 (de) | Einen grössenausschlussschritt verwendendes verbessertes bisulfit-verfahren | |
WO2007075672A3 (fr) | Marqueurs pour le pronostic du cancer | |
WO2005114203A3 (fr) | Épitopes dominants de cellules b et procédés de fabrication et d'utilisation de ceux-ci | |
WO2005033133A3 (fr) | Polynucleotides codant pour des nouveaux polypeptides erbb-2; trousses et methodes d'utilisation |